2Karkkainen MJ,Petrova TV.Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis[J].Oncogene,2000,19(49):5598-5605.
3Yamamoto S,Konishi I,Mandai M,et al.Expression of vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival,and analysis of serum VEGF levels [J].Br J Cancer,1997,76(9): 1221-1227.
4Nakanishi Y,Kodama J,Yoshinouchi M,et al.The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer [J].Int J Gynecol Pathol,1997,16(3): 256-262.
5Rossi JJ.Controlled,targeted,intracellular expression of ribozymes: progress and problems [J].Trends Biotechnol,1995,13(8): 301-306.
6Sandberg JA,Bouhana KS,Gallegos AM,et al.Pharmacokinetics of an antiangiogenic ribozyme (ANGIOZYME) in the mouse [J].Antisense Nucleic Acid Drug Dev,1999,9(3): 271-277.
7Ke LD,Fueyo J,Cheu X,et al.A novel approach to glioma gene therapy: down-regulation of the vascular endothelial growth factorin glioma cells using ribozymes [J].Int J Oncol,1998,12(6): 1391-1396.
8arry TJ,Cushman C,Gallegos AM,et al.Bioactivity of anti-angiogenic ribozymes targeting Flt-1 and KDR mRNA [J].Nucleic Acids Res,1999,27(13): 2569-2577.
